Navigating the Impact of Claims Data Volatility on Biopharma
On-demand webinar and executive brief on how claims data disruptions affect insights, operations, and ultimately, patients
November 2025
In biopharma, data volatility is an ongoing challenge, disrupting the real-world data (RWD) pipelines that drive critical insights needed to bring therapies to market. Causes for these data disruptions range from cyber threats and evolving regulations to supply chain disruptions and legacy systems, with consequences that reverberate across teams and impact decision-making and commercial strategy.
A recent McKesson Compile survey found that 68% of senior biopharma professionals in commercial roles experienced claims data volatility in the past year, leading to false insights, delayed decisions, and reassessment of data sourcing and management. With 99% expressing concern about future disruptions, proactive strategies are essential.
What this webinar covers
How claims data disruptions create false insights and delayed decisions
Which commercial use cases are most vulnerable to data volatility
Why sourcing different types of claims data helps to reduce risk
How teams can detect and mitigate disruptions while analyzing data
November 2025